Latest IR information
IR News
- 2025.10.30
- Summary of Consolidated Financial Statements for the First Nine Months of the Fiscal Year Ending December 31, 2025 [Japanese GAAP]
- 2025.10.28
- SymBio Receives MHRA Approval of its Pediatric Investigation Plan, a Requirement for Initiating the Global Phase 3 Study Evaluating IV Brincidofovir for the Treatment of Adenovirus Infection Post-HSCT in the United Kingdom
- 2025.10.27
- SymBio Presents Positive Efficacy Data for Brincidofovir in Head and Neck Cancer at ESMO 2025 (Berlin, Germany)
- 2025.10.24
- Notice Regarding Notice of the Large Volume Exercise of the 65th Stock Acquisition Rights (with Exercise Price Revision Clauses) Issued by way of Third-Party Allotment
- 2025.10.20
- Patent Obtained for a Groundbreaking Immunoassay with Ultra-High Sensitivity (detection at one part in a trillion)